Treatment of Lung Cancer
FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific [...]
Topotecan–Berzosertib Combination Effective for SCLC Treatment
Researchers all over the world are continuously been working towards finding effective treatments and therapies for lung cancer. There are widely two types of [...]
FDA Approves Libtayo as Monotherapy for Advanced NSCLC
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United [...]
NICE Recommends Keytruda Plus Chemo for NSCLC Treatment
National Institute for Health and Care Excellence (NICE) has recommended Keytruda, alongside a combination of pemetrexed and platinum chemotherapy for [...]
Study on New Combination of Immunotherapy Shows Promising Lung Cancer Treatment
In a recent study, researchers have established that a novel combination of two forms of immunotherapy can be highly effective in treatment of lung cancer. [...]
Lovelace Biomedical Provides New Formulation for Lung Cancer Treatment
Lung Cancer is a deadly disease taking away lives of hundreds of people every year. More and more studies and researches are being conducted in the arena for [...]
Early Treatment with Lorlatinib Helps in Improving Lung Cancer Survival Rate
Non-small cell lung cancer accounts for 87% of all lung cancer cases and some 5% of NSCLC cases are ALK-positive. This implies that they have genetic [...]
Post-Surgical Lung Cancer Treatments
Surgery is the treatment option for patients with non-small cell lung cancer. It might be the best option as it provides high chances of curing the disease. [...]
Proton Therapy for Lung Cancer May Help Prevent Heart Disease
Proton therapy for lung cancer treatment is a reasonable treatment for patients whose cancer is limited to the chest. The physicians are able to deliver highly [...]
Moffitt Researchers Develop Tool to Predict Lung Cancer Treatment
Choosing the right therapy for non-small cell lung cancer patient is not always an easy decision. Biomarkers can change during the therapy, making that [...]
New Study Identifies Drug to Boost Lung Cancer Survival Rates
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is [...]
Health Benefits of Fennel for Lung Cancer Patients
Lung Cancer is a serious health problem having no respect for age and sex and can affect any person at any interval of time. Various ayurvedic herbs help lung [...]
Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic [...]
Non-Smoking Lung Cancer Patients May Respond Differently to Treatment
Although smoking remains the main cause of lung cancer for most of the patients but there are other factors as well which may cause lung cancer. Non-smokers [...]
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]